Acrivon Therapeutics, Inc. reports additional corporate update

Acrivon Therapeutics, Inc. filed an 8-K covering other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.